Antibodies to hnRNP core proteins inhibit in vitro splicing of human beta-globin pre-mRNA.
AUTOR(ES)
Sierakowska, H
RESUMO
In vitro splicing of human beta-globin pre-mRNA can be fully inhibited by treatment of the splicing extract with polyclonal antibodies against hnRNP core proteins prior to the addition of pre-mRNA. Inhibition of the first step in the splicing pathway, cleavage at the 5' splice site and lariat formation, requires more antibodies than inhibition of the second step, cleavage at the 3' splice site and exon ligation. The anti-hnRNP antibodies can also inhibit the splicing reaction after the formation of the active nucleoprotein splicing complex which is known to occur during the initial lag period. Thus, hnRNP core proteins appear to be present in the complex that performs pre-mRNA splicing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=311538Documentos Relacionados
- Serine/threonine phosphorylation regulates binding of C hnRNP proteins to pre-mRNA.
- Inhibition of splicing but not cleavage at the 5' splice site by truncating human beta-globin pre-mRNA.
- Interplay between U2 snRNP and 3' splice factor(s) for branch point selection on human beta-globin pre-mRNA.
- RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing.
- Accurate in vitro splicing of human beta-globin RNA.
